eicosapentaenoic acid ethyl ester has been researched along with Hyperlipemia in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The decrease from pre-administration values was significant for patients with abnormal values in both dosage groups." | 1.29 | [The effect on changes in serum lipids and factors that may affect those changes after administration of icosapentaenoic acid ethyl ester]. ( Aoyama, T; Saga, T; Takekoshi, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, M | 1 |
| Ovbiagele, B | 1 |
| Saver, JL | 1 |
| Castaldo, RS | 1 |
| Yorioka, N | 1 |
| Masaki, T | 1 |
| Ito, T | 1 |
| Kushihata, S | 1 |
| Nishida, Y | 1 |
| Taniguchi, Y | 1 |
| Oda, H | 1 |
| Yamakido, M | 1 |
| Saga, T | 1 |
| Aoyama, T | 1 |
| Takekoshi, T | 1 |
| Yano, T | 1 |
| Mizuguchi, K | 1 |
| Takasugi, K | 1 |
| Tanaka, Y | 1 |
| Sato, M | 1 |
| Kurabayashi, T | 1 |
| Okada, M | 1 |
| Tanaka, K | 1 |
| Tsushima, M | 1 |
1 review available for eicosapentaenoic acid ethyl ester and Hyperlipemia
| Article | Year |
|---|---|
[Eicosapentaenoic acid].
Topics: Animals; CCAAT-Enhancer-Binding Proteins; Clinical Trials as Topic; DNA-Binding Proteins; Eicosapent | 2001 |
1 trial available for eicosapentaenoic acid ethyl ester and Hyperlipemia
| Article | Year |
|---|---|
Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group.
Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Eicosapentaenoic Acid; Estriol; Fe | 2000 |
5 other studies available for eicosapentaenoic acid ethyl ester and Hyperlipemia
| Article | Year |
|---|---|
Intensive Medical Management to Prevent Large and Small Artery Atherothrombotic Stroke: Time to Expand the Horizon.
Topics: Eicosapentaenoic Acid; Folic Acid; Glucagon-Like Peptide-1 Receptor; Humans; Hyperlipidemias; Hypogl | 2021 |
A retrospective case series of the lipid effects of switching from omega-3 fatty acid ethyl esters to icosapent ethyl in hyperlipidemic patients.
Topics: Aged; Azetidines; Eicosapentaenoic Acid; Esters; Ezetimibe; Fatty Acids, Omega-3; Female; Humans; Hy | 2014 |
Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Coagulation Factors; Drug Therapy, Combination; Eicosap | 2000 |
[The effect on changes in serum lipids and factors that may affect those changes after administration of icosapentaenoic acid ethyl ester].
Topics: Adult; Aged; Aged, 80 and over; Apoproteins; Cholesterol; Cholesterol, LDL; Eicosapentaenoic Acid; F | 1993 |
[Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on low density lipoprotein in rabbits].
Topics: Animals; Eicosapentaenoic Acid; Hyperlipidemias; Lipoproteins, LDL; Liver; Male; Mice; Platelet Aggr | 1995 |